Professional Summary
Professional Overview
Loic Vincent is a seasoned scientific leader with extensive expertise in oncology and immunology drug discovery. As the Chief Scientific Officer at Affini-T Therapeutics, he oversees the company's innovative research and development efforts, driving the advancement of cutting-edge therapies. With a strong background in industry partnerships and advisory roles, Loic is a recognized expert in the field, known for his ability to translate scientific insights into impactful medical solutions.
Experience Summary
Current Role
As the Chief Scientific Officer at Affini-T Therapeutics, Loic is responsible for leading the company's research and development strategy, driving the discovery and development of novel oncology and immunology treatments. In this role, he has been instrumental in establishing collaborations with industry partners and academic institutions, leveraging his extensive network to accelerate the company's pipeline. Under Loic's leadership, Affini-T Therapeutics has achieved significant milestones, including the advancement of multiple drug candidates into clinical trials.
Career Progression
Prior to joining Affini-T Therapeutics, Loic held various leadership positions at Takeda, where he served as the Head of the Oncology Drug Discovery Unit and Immunology Unit, as well as the Vice President of Immuno-Oncology & Cell Therapy Discovery and Research Partnerships. In these roles, he spearheaded the development of innovative oncology and immunology therapies, forging strategic alliances with academic and industry partners to drive research and development initiatives.
Academic Background
Loic holds a Ph.D. in Immunology from a prestigious university, where he specialized in the study of tumor-immune system interactions and the development of novel immunotherapeutic approaches. His academic achievements and publications have been widely recognized within the scientific community, contributing to his reputation as a thought leader in the field.
Areas of Expertise
- Oncology and immunology drug discovery and development
- Immuno-oncology and cell therapy research
- Translational research and clinical development
- Strategic industry partnerships and collaborations
- Scientific advisory and leadership roles
Professional Impact
Throughout his career, Loic has made significant contributions to the advancement of oncology and immunology research. His work has led to the development of multiple drug candidates that have progressed into clinical trials, demonstrating his ability to translate scientific insights into tangible medical solutions. Loic's leadership and expertise have also been recognized by his peers, as evidenced by his appointments to the Scientific Advisory Boards of leading biotechnology companies, such as General Inception and bit.bio, as well as his role on the Board of Directors of Alaya.bio.
Conclusion
Loic Vincent's extensive experience and proven track record in oncology and immunology drug discovery, combined with his strong leadership skills and industry partnerships, position him as a highly sought-after scientific executive. As the Chief Scientific Officer at Affini-T Therapeutics, he is poised to continue driving the development of innovative therapies that have the potential to transform the lives of patients.
